Related Experiment Video
Updated: Mar 12, 2026
Preparation of Mitochondrial Enriched Fractions for Metabolic Analysis in Drosophila
Published on: September 30, 2015
Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila
Nikolay P Kandul1, Ting Zhang2,3, Bruce A Hay1
1Division of Biology and Biological Engineering, California Institute of Technology, Mail Code 156-29, 1200 E. California blvd., Pasadena, California 91125, USA.
Abstract:
Mitochondrial DNA (mtDNA) often exists in a state of heteroplasmy, in which mutant mtDNA co-exists in cells with wild-type mtDNA. High frequencies of pathogenic mtDNA result in maternally inherited diseases; maternally and somatically acquired mutations also accumulate over time and contribute to diseases of ageing. Reducing heteroplasmy is therefore a therapeutic goal and in vivo models in post-mitotic tissues are needed to facilitate these studies. Here we describe a transgene-based model of a heteroplasmic lethal mtDNA deletion (mtDNAΔ) in adult Drosophila muscle. Stimulation of autophagy, activation of the PINK1/parkin pathway or decreased levels of mitofusin result in a selective decrease in mtDNAΔ. Decreased levels of mitofusin and increased levels of ATPIF1, an inhibitor of ATP synthase reversal-dependent mitochondrial repolarization, result in a further decrease in mtDNAΔ levels. These results show that an adult post-mitotic tissue can be cleansed of a deleterious genome, suggesting that therapeutic removal of mutant mtDNA can be achieved.
Insights
Researchers developed a Drosophila model to reduce mutant mitochondrial DNA (mtDNA) heteroplasmy. Activating specific pathways selectively decreased mutant mtDNA, suggesting a therapeutic strategy for inherited and age-related diseases.
Area of Science:
- Mitochondrial biology
- Genetics
- Aging research
Background:
- Mitochondrial DNA (mtDNA) heteroplasmy, the coexistence of mutant and wild-type mtDNA, is linked to inherited diseases and aging.
- Therapeutic strategies to reduce mutant mtDNA levels are crucial for treating these conditions.
Purpose of the Study:
- To establish an in vivo model for studying mutant mtDNA reduction in post-mitotic tissues.
- To identify pathways and interventions that can selectively decrease heteroplasmic mutant mtDNA.
Main Methods:
- Development of a transgene-based Drosophila model expressing a heteroplasmic lethal mtDNA deletion (mtDNAΔ) in adult muscle.
- Investigated the effects of stimulating autophagy, activating the PINK1/parkin pathway, and altering mitofusin levels on mtDNAΔ levels.
- Examined the role of ATPIF1 in modulating mtDNAΔ levels.
Main Results:
- Stimulating autophagy, activating the PINK1/parkin pathway, or reducing mitofusin selectively decreased mutant mtDNAΔ levels.
- Further reduction of mtDNAΔ was achieved by decreasing mitofusin and increasing ATPIF1.
- Demonstrated successful clearance of a deleterious mitochondrial genome in adult post-mitotic tissue.
Conclusions:
- The developed Drosophila model effectively reduces mutant mtDNA heteroplasmy in adult muscle.
- Identified specific pathways and molecular interventions for the therapeutic removal of mutant mtDNA.
- Suggests the potential for clinical strategies to eliminate deleterious mtDNA and treat related diseases.
